You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
« Previous
Version 38
Next »
Term | description type | Language/acceptability | Language/acceptability | Case Significance |
---|
Product containing [substance] in [pharmaceutical dose form] (medicinal product form) | FSN | us:P | gb:P | ci |
[substance]-containing product in [pharmaceutical dose form] | SYN | us:P | gb:P | ci |
Role group cardinality | Attribute cardinality | Attribute in role group cardinality | Attribute | Value |
---|
0..0 | 1..1 |
| | |
0..0 | 1..1 |
| | |
1..* |
| 1..1 | | |
900000000000073002 |Defined|
- Apply General rules for generating descriptions for templates
- 'and [substance]' needs to be added for FSN for multiple |has active ingredient| and they are self grouped, e.g. Product containing calcium carbonate and light kaolin in oral dose form (medicinal product form)
- '[substance]- and' needs at the beginning of the description to be added for PT for multiple |has active ingredient| and they are self grouped, e.g. calcium carbonate- and light kaolin-containing product in oral dose form
- For multiple ingredients, the ingredients in each description need to be in alphabetical order e.g. Codeine and paracetamol for FSN but Acetaminophen and codeine (for US PT).
DRUGS-275
-
Getting issue details...
STATUS
INFRA-3052
-
Getting issue details...
STATUS
DRUGS-643
-
Getting issue details...
STATUS